Business Context and Reporting Period
Company: Aspen Aerogels, Inc. (ASPN)
Filing Type: Form 8-K (Current Report)
Report Date: August 2, 2023
Period Covered: Second Quarter of 2023 (ended June 30, 2023)
This filing announces the financial results for the second quarter of 2023 and discusses business developments. Detailed financial data and the 2023 Financial Outlook are incorporated by reference from the attached press release (Exhibit 99.1), which is not included in the provided text.
Key Financial Metrics
The provided filing text serves as a cover document and does not contain specific numerical values for the following metrics. Investors must refer to the attached press release (Exhibit 99.1) for data on:
- Revenue
- Profit (Net Income/Loss)
- Cash Flow
- Margins (Gross, Operating, Net)
- Debt Levels
- Liquidity Position
Note: The filing text does not provide a clear value for any specific financial metric.
Material Changes
The filing indicates that the company announced results and discussed business developments. However, the text does not specify the nature or magnitude of material changes compared to the prior comparable period. Specific comparisons are contained within the referenced press release.
Guidance, Outlook, and Risks
Guidance and Outlook: The filing explicitly incorporates the "2023 Financial Outlook" from the attached press release into Item 7.01 (Regulation FD Disclosure). Specific guidance figures are not present in this text.
Risks and Contingencies: The filing includes a standard disclaimer regarding forward-looking statements found in the press release. No specific new risks or contingencies are detailed in the 8-K text itself.
Investor Verification Checklist
- Verify the specific Q2 2023 revenue and net income figures in the attached press release (Exhibit 99.1).
- Review the "2023 Financial Outlook" section in the press release for updated full-year guidance.
- Confirm the details of "business developments" mentioned in the announcement.
- Check the forward-looking statement disclaimer in the press release for specific risk factors.